Skip to main content
. 2014 Oct 21;4(10):e471. doi: 10.1038/tp.2014.111

Table 4. Top associated genes with heterogenous variation across multiple individuals.

          Allele frequency in each population
Gene Phevor score Phevor  P-value SNP; locus Variant; AA change Asthma risk group, % (n=28) Other UT suicides, % (n=432) (gene P-value) CEU/GBR, % (n=183) (gene P-value)
TLR3 3.16 0.0007 rs112077022; chr4:187003678 G/A; D/N 1.80 0 (0.0314) 0 (0.0442)
      rs199768900; chr4:187005912 G/A; R/Q 1.80 0.12 (0.0314) 0 (0.0442)
ALAS2 2.98 0.0011 rs201799139; chrX:55035659 G/A; S/F 2.80 0 (0.00838) 0.36 (0.0442)
      rs201062903; chrX:55039960 G/A; P/L 2.80 0 (0.00838) 0 (0.0442)
      rs145704441; chrX:55035701 C/T; R/H 2.80 0 (0.00838) 0 (0.0442)
FAM184B 2.6 0.0025 rs61742285; chr4:17640880 C/G; E/Q 5.40 3.4 (0.0456) 0.83 (0.00094)
      rs61746992; chr4:17710586 C/G; D/H 1.80 0.23 (0.0456) 0 (0.00094)
      rs61746445; chr4:17711210 G/A; R/W 1.80 0.46 (0.0456) 0 (0.00094)
      rs191859569; chr4:17654594 G/A; R/C 1.80 0 (0.0456) 0.35 (0.00094)
      rs151185488; chr4:17707448 C/G; G/A 1.80 0.81 (0.0456) 0 (0.00094)
NCAM2 2.43 0.0037 rs200376885; chr21:22652906 C/A; Q/K 1.80 0.23 (0.0428) 0 (0.0357)
      rs200645709; chr21:22658669 A/G; S/G 1.80 0 (0.0428) 0 (0.0357)
SLC22A11 2.39 0.0041 rs35008345; chr11:64323613 C/T; R/* 1.80 0.12 (0.0314) 0 (0.03)
      rs147522958; chr11:64331790 G/A; E/K 1.80 0.23 (0.0314) 0 (0.03)
KRTAP27-1 2.31 0.0049 rs144648271; chr21:31709731 G/A; Q/* 3.60 0.12 (0.00742) 0 (0.0266)
      rs139988725; chr21:31709679 T/A; E/V 1.80 0.12 (0.00742) 0.55 (0.0266)
PCDHGB5 2.28 0.0053 rs140768844; chr5:140768844 C/T; P/S 1.80 0.23 (0.0471) 0 (0.0456)
      rs199849689; chr5:140790021 C/T; S/F 1.80 0.12 (0.0471) 0.43 (0.0456)
      rs199531162; chr5:140789304 G/C; G/A 1.80 0 (0.0471) 0 (0.0456)
CDK6 2.18 0.0065 rs14049009; chr7:92244486 T/A; S/C 1.80 0.35 (0.0485) 0 (0.0227)
      rs35654944; chr7:92404051 C/T; D/N 1.80 0.23 (0.0485) 0.55 (0.0227)
VTN 2.15 0.007 rs140531078; chr17:26695904 T/C; Y/C 1.90 0 (0.00619) 0 (0.0187)
      rs113837940; chr17:26694852 G/A; S/F 1.80 0 (0.00619) 0 (0.0187)
DAB2IP 2.13 0.0074 rs117152313; chr9:124544697 C/T; R/C 1.90 0.23 (0.0485) 0 (0.018)
      rs143836788; chr9:124536561 A/G; N/S 1.90 0 (0.00619) 0 (0.018)
      rs141706892; chr9:124526082 G/A; A/T 1.80 0.12 (0.0442) 0 (0.018)
R3HDM1 2.05 0.0088 rs34088964; chr2:136396212 A/C; I/L 3.60 0.35 (0.0399) 0 (0.00213)
      rs151233134; chr2:136418898 C/T; P/L 1.80 0.12 (0.0399) 0 (0.00213)
      rs2305165; chr2:136409574 A/C; Q/P 10.70 8.5 (0.0399) 6.83 (0.00213)
PLEKHG3 2.01 0.0097 rs141719183; chr14:65205490 A/G; R/G 3.60 0.23 (0.0471) 0.27 (0.0286)
      rs142732386; chr14:65198849 C/T; H/Y 1.80 0.12 (0.0471) 0 (0.0286)

Abbreviations: *, stop codon/nonsense; ALAS2, delta aminolevulinate synthase 2; CDK6, cyclin-dependent kinase 6; CEU, western European ancestry; DAB2IP, DAB2 interacting protein; FAM184B, family with sequence similarity 184, member B; GBR, British in England and Scotland; KRTAP27-1, keratin associated protein 27-1; NCAM2, neural cell adhesion molecule 2; PCDHGB5, protocadherin gamma subfamily B, 5; Phevor, phenotype driven variant ontological re-ranking tool; PLEKHG3, pleckstrin homology domain containing, family G, member 3; R3HDM1, R3H domain containing 1; SLC22A11, solute carrier family 22, member 11; SNP, single-nucleotide polymorphism; TLR3, Toll-like receptor 3; UT, Utah; VTN, vitronectin.

All pVAAST (pedigree extension of the Variant Annotation, Analysis and Search Tool) P-values were computed using 109 permutations. Frequencies between each group were calculated using chromosome counts, accounting for subjects with no calls. No homozygotes were observed for these variants.